Title : The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions.

Pub. Date : 1999 Dec 16

PMID : 10716232






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid cholinergic receptor nicotinic alpha 2 subunit Rattus norvegicus
2 The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid fibroblast growth factor 2 Rattus norvegicus
3 The present experiments were designed to extend previous work showing that acute intermittent (-)nicotine treatment upregulates the level of fibroblast growth factor-2 (FGF2) mRNA in several rat brain regions, by the use of the nicotinic acetylcholine receptor (nAChR) agonist ABT-594 with preferential selectivity for the alpha4beta2 nAChR subtype. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid fibroblast growth factor 2 Rattus norvegicus
4 The present experiments were designed to extend previous work showing that acute intermittent (-)nicotine treatment upregulates the level of fibroblast growth factor-2 (FGF2) mRNA in several rat brain regions, by the use of the nicotinic acetylcholine receptor (nAChR) agonist ABT-594 with preferential selectivity for the alpha4beta2 nAChR subtype. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid fibroblast growth factor 2 Rattus norvegicus
5 The effects of ABT-594 on FGF-2 expression were antagonized by the preferential alpha4beta2 antagonist dihydrobetaerythroidine (DHbetaE), but not by alpha7 antagonist methyllycaconitine (MLA). 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid fibroblast growth factor 2 Rattus norvegicus